Update on optimal use of lisdexamfetamine in the treatment of ADHD

References

• TurgayAGoodmanDWAshersonPLifespan persistence of ADHD: the life transition model and its applicationJ Clin Psychiatry201273219220122313720
   PubMed Web of Science ®Google Scholar
• PliszkaSRAttention-deficit/hyperactivity disorderDulcan’s Textbook of Child and Adolescent Psychiatry1st edArlington, VAAmerican Psychiatric Publishing Inc2010 Available from http://www.ap.psychiatryonline.org/content.aspx?bookid=24&sectionid=1311465Accessed June 13, 2013
   Google Scholar
• PolanczykGde LimaMSHortaBLBiedermanJRohdeLAThe worldwide prevalence of ADHD: a systematic review and metaregression analysisAm J Psychiatry2007164694294817541055
   PubMed Web of Science ®Google Scholar
• BrownRTAmlerRWFreemanWSTreatment of attention-deficit/hyperactivity disorder: overview of the evidencePediatrics20051156e749e75715930203
   PubMed Web of Science ®Google Scholar
• DaughtonJMKratochvilCJReview of ADHD pharmacotherapies: advantages, disadvantages, and clinical pearlsJ Am Acad Child Adolesc Psychiatry200948324024819242289
   PubMed Web of Science ®Google Scholar
• CascadeEKalaliAHWeislerRHShort-acting versus long-acting medications for the treatment of ADHDPsychiatry (Edgmont)200858242719727272
   PubMedGoogle Scholar
• MadaanVLisdexamfetamine dimesylate for childhood ADHDDrugs Today (Barc)200844531932418548134
   PubMed Web of Science ®Google Scholar
• DomniteiDMadaanVNew and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and childrenNeuropsychiatr Dis Treat2010627327920520740
   PubMed Web of Science ®Google Scholar
• GoodmanDWLisdexamfetamine dimesylate: the first prodrug stimulantPsychiatry (Edgmont)200748394520532026
   PubMedGoogle Scholar
• PennickMAbsorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamineNeuropsychiatr Dis Treat2010631732720628632
   PubMed Web of Science ®Google Scholar
• KrishnanSMoncriefSAn evaluation of the cytochrome p450 inhibition potential of lisdexamfetamine in human liver microsomesDrug Metab Dispos200735118018417035599
   PubMed Web of Science ®Google Scholar
• KrishnanSMStarkJGMultiple daily-dose pharmacokinetics of lisdexamfetamine dimesylate in healthy adult volunteersCurr Med Res Opin2008241334018021493
   PubMed Web of Science ®Google Scholar
• ErmerJCHaffeyMBDollWJPharmacokinetics of lisdexamfetamine dimesylate after targeted gastrointestinal release or oral administration in healthy adultsDrug Metab Dispos201240229029722039171
   PubMed Web of Science ®Google Scholar
• KrishnanSZhangYRelative bioavailability of lisdexamfetamine 70-mg capsules in fasted and fed healthy adult volunteers and in solution: a single-dose, crossover pharmacokinetic studyJ Clin Pharmacol200848329330218285619
   PubMed Web of Science ®Google Scholar
• BoellnerS WStarkJGKrishnanSZhangYPharmacokinetics of lisdexamfetamine dimesylate and its active metabolite, d-amphetamine, with increasing oral doses of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: a single-dose, randomized, open-label, crossover studyClin Ther201032225226420206783
   PubMed Web of Science ®Google Scholar
• ErmerJCDennisKHaffeyMBIntranasal versus oral administration of lisdexamfetamine dimesylate: a randomized, open-label, two-period, crossover, single-dose, single-centre pharmacokinetic study in healthy adult menClin Drug Investig2011316357370
   PubMed Web of Science ®Google Scholar
• BiedermanJBoellnerS WChildressALopezFAKrishnanSZhangYLisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom studyBiol Psychiatry200762997097617631866
   PubMed Web of Science ®Google Scholar
• BiedermanJKrishnanSZhangYMcGoughJJFindlingRLEfficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group studyClin Ther200729345046317577466
   PubMed Web of Science ®Google Scholar
• FindlingRLChildressACKrishnanSMcGoughJJLong-term effectiveness and safety of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorderCNS Spectr200813761462018622366
   PubMed Web of Science ®Google Scholar
• HammernessPZusmanRSystromDA cardiopulmonary study of lisdexamfetamine in adults with attention-deficit/hyperactivity disorderWorld J Biol Psychiatry201314429930622559155
   PubMed Web of Science ®Google Scholar
• MoraSRedbergRFCuiYAbility of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence studyJAMA200324290121600160714506119
   PubMed Web of Science ®Google Scholar
• FindlingRLGinsbergLDJainRGaoJEffectiveness, safety, and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: an open-label, dose-optimization studyJ Am Acad Child Adolesc Psychiatry2009196649662
   Google Scholar
• WigalSBWongAAJunAStehliASteinberg-EpsteinRLernerMAAdverse events in medication treatment-naïve children with attention-deficit/hyperactivity disorder: results from a small, controlled trial of lisdexamfetamine dimesylateJ Child Adolesc Psychopharmacol201222214915622372513
   PubMed Web of Science ®Google Scholar
• GiblinJMStrobelALEffect of lisdexamfetamine dimesylate on sleep in children with ADHDJ Atten Disord201115649149820574056
   PubMed Web of Science ®Google Scholar
• FaraoneS VSpencerTJKollinsSHGlattSJEffects of lisdexamfetamine dimesylate treatment for ADHD on growthJ Am Acad Child Adolesc Psychiatry2010491243220215923
   PubMed Web of Science ®Google Scholar
• FindlingRLChildressACCutlerAJEfficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorderJ Am Acad Child Adolesc Psychiatry201150439540521421179
   PubMed Web of Science ®Google Scholar
• AdlerLAGoodmanDWKollinsSHDouble-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorderJ Clin Psychiatry20086991364137319012818
   PubMed Web of Science ®Google Scholar
• WeislerRYoungJMattinglyGLong-term safety and effectiveness of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorderCNS Spectr2009141057358520095369
   PubMed Web of Science ®Google Scholar
• MattinglyGWeislerRDirksBAttention deficit hyperactivity disorder subtypes and symptom response in adults treated with lisdexamfetamine dimesylateInnov Clin Neurosci201295–6223022808446
   PubMedGoogle Scholar
• BramsMWeislerRFindlingRLMaintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: randomized withdrawal designJ Clin Psychiatry201273797798322780921
   PubMed Web of Science ®Google Scholar
• AdlerLALynchLRShawDMEffectiveness and duration of effect of open-label lisdexamfetamine dimesylate in adults with ADHDJ Atten Disord582013 [Epub ahead of print.]
   Google Scholar
• JainRBabcockTBurteaTEfficacy and safety of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder and recent methylphenidate useAdv Ther5172013 [Epub ahead of print.]
   Web of Science ®Google Scholar
• WigalSBKollinsSHChildressACSquiresLA 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorderChild Adolesc Psychiatry Ment Health2009311719508731
   PubMedGoogle Scholar
• WigalSBMaltasSCrinellaFReading performance as a function of treatment with lisdexamfetamine dimesylate in elementary school children diagnosed with ADHDJ Atten Disord2012161233320978273
   PubMed Web of Science ®Google Scholar
• TurgayAGinsbergLSarkisEExecutive function deficits in children with attention-deficit/hyperactivity disorder and improvement with lisdexamfetamine dimesylate in an open-label studyJ Child Adolesc Psychopharmacol201020650351121186969
   PubMed Web of Science ®Google Scholar
• KaticAGinsbergLJainRClinically relevant changes in emotional expression in children with ADHD treated with lisdexamfetamine dimesylateJ Atten Disord201216538439721173426
   PubMed Web of Science ®Google Scholar
• BrownTEBramsMGaoJGasiorMChildressAOpen-label administration of lisdexamfetamine dimesylate improves executive function impairments and symptoms of attention-deficit/hyperactivity disorder in adultsPostgrad Med2012122571720861583
   PubMed Web of Science ®Google Scholar
• WigalTBramsMGasiorMRandomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment designBehav Brain Funct2012613420576091
   PubMed Web of Science ®Google Scholar
• DupaulGJWeyandtLLRossiJSDouble-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in college students with ADHDJ Atten Disord201216320222022166471
   PubMed Web of Science ®Google Scholar
• BiedermanJFriedRHammernessPThe effects of lisdexamfetamine dimesylate on the driving performance of young adults with ADHD: a randomized, double-blind, placebo-controlled study using a validated driving simulator paradigmJ Psychiatr Res201246448449122277301
   PubMed Web of Science ®Google Scholar
• DonovanSJLevinFRThe “younger-sibling-at-risk design”: a pilot study of adolescents with ADHD and an older sibling with substance use disorderAm J Drug Alcohol Abuse2011374023523921517711
   PubMed Web of Science ®Google Scholar
• JasinskiDRKrishnanSHuman pharmacology of intravenous lisdexamfetamine dimesylate: abuse liability in adult stimulant abusersJ Psychopharmacol200923441041818635707
   PubMed Web of Science ®Google Scholar
• WeberJSiddiquiMALisdexamfetamine dimesylate: in attention-deficit hyperactivity disorder in adultsCNS Drugs200923541942519453202
   PubMed Web of Science ®Google Scholar
• BirnbaumHGKesslerRCLoweS WCosts of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000Curr Med Res Opin200521219520615801990
   PubMed Web of Science ®Google Scholar
• WuEQHodgkinsPBen-HamadiRCost effectiveness of pharmacotherapies for attention-deficit hyperactivity disorder: a systematic literature reviewCNS Drugs201226758160022712698
   PubMed Web of Science ®Google Scholar
• YoungJLUse of lisdexamfetamine dimesylate in treatment of executive functioning deficits and chronic fatigue syndrome: a double blind, placebo-controlled studyPsychiatry Res20132071–212713323062791
   PubMed Web of Science ®Google Scholar